Quick Takeaways
- Charles D. Pauza has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $296,885.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Charles D. Pauza
- Location
- Newtown, PA
- Summary
- The estimated net worth of Charles D. Pauza is at least $296,885 dollars as of 10 Mar 2026. Charles D. Pauza is the Chief Science Officer Virology of Traws Pharma, Inc. and owns shares of Traws Pharma, Inc. (TRAW) stock worth about $296.9K.
- Signature
- /s/ Charles D. Pauza
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Charles D. Pauza and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Traws Pharma, Inc. ($296,885).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Charles D. Pauza
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | Chief Science Officer Virology | $296,885 | 08 Mar 2026 |
Insider Transactions Reported by Charles D. Pauza:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.